Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/25/2018
Betta Pharma to Reduce Price of Anticancer by 4% after Government Talk...
7/25/2018
WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection
7/25/2018
Sanofi Gets Chinese Approval of Its MS Drug Audagio
7/24/2018
Bayer Wins Chinese Approval of Hemophilia A Drug
7/24/2018
XiAn Janssen's HIV Drug Prezcobix Approved in China
7/24/2018
Novartis Oncology Launches TPO-RA Agent Revolade in China
7/24/2018
Tencent Licenses WebMD Contents for Provision thru WeChat
7/24/2018
BeiGene Reports Progress of Pivotal Trial for Anti-PD-1 Antibody in Ho...
7/23/2018
Janssen's Yi Ke Granted Indication Expansion to CLL/ SLL in China
7/20/2018
CNDA Issues Guiding Principles for the Acceptance of Overseas Clinical...
7/20/2018
WuXi STA and Antengene Sign Development and Manufacturing Agreement
7/19/2018
SAMR Seeks Comments for Draft Document on Medical Institution Formulat...
7/19/2018
Tasly Licenses China Rights of Kidney Disease Drug from EA Pharma
7/18/2018
New Report: China's CDMO Market to Boom by 2021
7/18/2018
Mesoblast Enters Into Strategic Cardiovascular Alliance for China With...
7/17/2018
Xinhua: China's New Drug for Alzheimer's Completes Phase 3 Trial
7/17/2018
State Council Revamps Healthcare Reform Leading Group
7/17/2018
China Embraces Another Vaccine Scandal
7/16/2018
Shanghai AIC Officially Terminates Antimonopoly Investigation of the C...
7/13/2018
Recent Executive Moves
7/13/2018
CNDA Solicits Comments on GMP for Clinical Trial Drugs
7/13/2018
SMIA Mulls Tender for Anticancers as It Plans New Mechanism for Updati...
7/12/2018
Merck and Xian Janssen to Co-launch Type 2 Diabetes Drug in China
7/11/2018
Shanghai Unveils New Open Policy Measures, Benefiting Pharma/MedTech I...
7/11/2018
CDE Solicits Comments on Technical Requirements for Topical Dermatolog...
7/10/2018
Ping An Reportedly to Make Rival Offer for China Biologic
7/10/2018
CNDA Issues Technical Guidelines for Acceptance of Foreign Drug Clinic...
7/10/2018
iBio Establishes Strategic Commercial Relationship with CC-Pharming
7/10/2018
China Agrees to Slash Import Duties on Indian Medicines
7/10/2018
China's Biopharma Rise: Opportunities and Threats
Page:
159
/
357
Total number of articles:
10705
:
[First]
[<<]
[157]
[158]
[159]
[160]
[161]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit